New implant aims to tame hard-to-treat seizures
Disease control
Not yet recruiting
This study tests a new device called the iVEAcare Neuromodulation System for people with drug-resistant epilepsy, whose seizures are not controlled by medication. About 30 participants will receive the implant and be followed for up to 5 years. Researchers will check for side eff…
Phase: NA • Sponsor: iVEAcare • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC